Ochsner Health announced Paul J. Kenny, PhD as the 2020 recipient of the annual Alton Ochsner Award Relating Smoking and Disease, which recognizes scientific research achievements that provide major insights into the biological mechanisms relating tobacco smoking and human disease.
July 8, 2020—Ochsner Health, Louisiana's largest non-profit academic healthcare system, annouced Paul J. Kenny, PhD, as the recipient of the 35th annual Alton Ochsner Award Relating Smoking and Disease. Kenny is a Ward-Coleman professor and chair of the Nash Family Department of Neuroscience at the Icahn School of Medicine at Mount Sinai in new York.
The award is named after Alton Ochsner, MD, who, in 1939, published the first evidence indicating tobacco smoking was the makor cause of lung cancer. Kenny's research focused on nicotine addiction and provided insights for the development of new treatment methods. In particular, Kenny demonstrated the relevance of glucagon-like peptide to the regulation of nicotine craving.
"As our 2020 honoree, Dr. Kenny joins the ranks of other research giants in this field for his contributions studying nicotine addition,” said Leonardo Seoane, MD, chief academic officer of Ochsner Health.
Read the full press release here.
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
April 30th 2024"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of Evidence-Based Oncology.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More